{"transactions":[{"id":727746,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T23:09:49.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":false,"shares":34620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests as to 25% on September 30, 2020 and in equal monthly installments thereafter over the following three years, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":220190,"derivative":{"exercise_price":1.74,"expiration_date":"2030-01-21","underlying":"Class A Common Stock","underlying_shares":34620},"source":{"system":"sec-edgar","filing":"0001734780-26-000004","document":"form4-06242026_110645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/form4-06242026_110645.xml","form_type":"4"}},{"id":727745,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T23:09:49.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":false,"shares":90380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":409620,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":90380},"source":{"system":"sec-edgar","filing":"0001734780-26-000004","document":"form4-06242026_110645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/form4-06242026_110645.xml","form_type":"4"}},{"id":727744,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:09:49.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":125000,"price":6.0255,"value":753187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.085. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32591,"source":{"system":"sec-edgar","filing":"0001734780-26-000004","document":"form4-06242026_110645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/form4-06242026_110645.xml","form_type":"4"}},{"id":727743,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:09:49.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":true,"shares":34620,"price":1.74,"value":60238.8,"ownership":{"direct":true},"balance_after":157591,"source":{"system":"sec-edgar","filing":"0001734780-26-000004","document":"form4-06242026_110645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/form4-06242026_110645.xml","form_type":"4"}},{"id":727742,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:09:49.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":true,"shares":90380,"price":1.87,"value":169010.6,"ownership":{"direct":true},"balance_after":122971,"source":{"system":"sec-edgar","filing":"0001734780-26-000004","document":"form4-06242026_110645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/form4-06242026_110645.xml","form_type":"4"}},{"id":867964,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T00:59:11.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":748130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":748130,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":748130},"source":{"system":"sec-edgar","filing":"0001734780-26-000003","document":"form4-03042026_120307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000003/form4-03042026_120307.xml","form_type":"4"}},{"id":1106406,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:05:21.000Z","date":"2025-06-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.71,"value":17100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":29591,"source":{"system":"sec-edgar","filing":"0001415889-25-017660","document":"form4-06182025_040613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925017660/form4-06182025_040613.xml","form_type":"4"}},{"id":1229184,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T23:35:24.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.97,"expiration_date":"2035-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-25-006699","document":"form4-03042025_110320.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925006699/form4-03042025_110320.xml","form_type":"4"}},{"id":1603436,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T22:24:09.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-24-006310","document":"form4-03042024_100304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588924006310/form4-03042024_100304.xml","form_type":"4"}},{"id":1979872,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T23:02:06.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date"}],"balance_after":500000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-23-014892","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919123014892/doc4.xml","form_type":"4"}},{"id":2170031,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-31T21:17:57.000Z","date":"2022-08-29","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date"}],"balance_after":450000,"derivative":{"exercise_price":2.93,"expiration_date":"2032-08-28","underlying":"Class A Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001209191-22-048154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919122048154/doc4.xml","form_type":"4"}},{"id":2361193,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T21:57:28.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/28/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date"}],"balance_after":500000,"derivative":{"exercise_price":5.06,"expiration_date":"2032-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-22-014825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919122014825/doc4.xml","form_type":"4"}},{"id":2863790,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-12T22:50:09.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":254810,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea Acquisition Corp. (\"Panacea\") and Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in exchange for an option to purchase 254,810 shares of Legacy Nuvation Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options vest as to 25% on September 30, 2020 and in equal monthly installments thereafter over the following three years."}],"balance_after":254810,"derivative":{"exercise_price":1.74,"expiration_date":"2030-01-21","underlying":"Class A Common Stock","underlying_shares":254810},"source":{"system":"sec-edgar","filing":"0001209191-21-010344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919121010344/doc4.xml","form_type":"4"}},{"id":2863789,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Human Resources"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-12T22:50:09.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":398935,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea Acquisition Corp. (\"Panacea\") and Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc. (the \"Issuer\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in exchange for an option to purchase 398,935 shares of Legacy Nuvation Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest as to 20% on October 5, 2023, 20% on October 5, 2023 and 60% on October 5, 2025, subject to achievement of performance criteria."}],"balance_after":398935,"derivative":{"exercise_price":4.6,"expiration_date":"2030-10-04","underlying":"Class A Common Stock","underlying_shares":398935},"source":{"system":"sec-edgar","filing":"0001209191-21-010344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919121010344/doc4.xml","form_type":"4"}},{"id":3581872,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Human Resources"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-03-22T23:26:33.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 21, 2018, the reporting person was granted a performance based option to purchase 62,500 shares of common stock based on a specific performance metric. On March 20, 2019, it was determined that the performance metric had been met."}],"balance_after":62500,"derivative":{"exercise_price":3.94,"expiration_date":"2028-03-21","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001179110-19-004211","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019004211/edgar.xml","form_type":"4"}},{"id":3686938,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Human Resources"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-25T23:41:24.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":137500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019."}],"balance_after":137500,"derivative":{"exercise_price":2,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":137500},"source":{"system":"sec-edgar","filing":"0001179110-19-000936","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911019000936/edgar.xml","form_type":"4"}},{"id":3984099,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Human Resources"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-23T22:18:48.000Z","date":"2018-03-21","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the option vests one year from March 19, 2018 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months."}],"balance_after":125000,"derivative":{"exercise_price":3.94,"expiration_date":"2028-03-21","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001179110-18-004818","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018004818/edgar.xml","form_type":"4"}}]}